GlassScriptPhysician profile
Dione Marcus Super
NPI 1598974503
$13,609.76
in general payments reported to CMS, 2019-2025
49 companies · $2,141 in 2025
The $2,141 reported for 2025 was more than what 77% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,915 · 2020: $1,226 · 2021: $1,255 · 2022: $1,834 · 2023: $2,486 · 2024: $2,753 · 2025: $2,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,223 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,223.19 |
| Education | $156.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,876.71 | 2019-2025 | |
| Janssen Biotech, INC. | $1,468.29 | 2019-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $1,079.03 | 2019-2025 | |
| Leo Pharma INC. | $821.46 | 2019-2025 | Adbry, Anzupgo |
| Pfizer INC. | $672.29 | 2019-2025 | |
| Dermavant Sciences, INC. | $664.49 | 2022-2024 | Vtama |
| Galderma Laboratories, L.P. | $659.44 | 2019-2025 | Aklief, Nemluvio |
| Mayne Pharma Commercial LLC | $592.87 | 2019-2025 | |
| Lilly USA, LLC | $498.36 | 2019-2025 | Taltz, Ebglyss |
| Sun Pharmaceutical Industries INC. | $451.06 | 2019-2025 | Winlevi |
| Amgen INC. | $411.45 | 2020-2025 | Otezla, Enbrel, Otezla |
| Almirall LLC | $405.04 | 2019-2025 | Seysara, Klisyri |
| Arcutis Biotherapeutics, INC. | $370.83 | 2023-2025 | Zoryve |
| Incyte Corporation | $366.79 | 2021-2025 | Opzelura |
| Vyne Pharmaceuticals INC. | $327.03 | 2020-2021 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dione Super listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.